DHG Pharmaceutical JSC (HOSE:DHG)
Vietnam
· Delayed Price · Currency is VND 99,700
+200 (0.20%)
At close: Apr 28, 2026
DHG Pharmaceutical JSC Income Statement
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 5,270,518 | 5,266,963 | 4,884,868 | 5,015,395 | 4,676,016 | 4,003,170 | Upgrade
|
| Revenue Growth (YoY) | 9.33% | 7.82% | -2.60% | 7.26% | 16.81% | 6.59% | Upgrade
|
| Cost of Revenue | 2,731,308 | 2,760,594 | 2,747,102 | 2,671,850 | 2,418,521 | 2,082,260 | Upgrade
|
| Gross Profit | 2,539,210 | 2,506,369 | 2,137,766 | 2,343,545 | 2,257,495 | 1,920,911 | Upgrade
|
| Selling, General & Admin | 1,542,412 | 1,553,700 | 1,217,491 | 1,291,264 | 1,181,417 | 1,060,127 | Upgrade
|
| Operating Expenses | 1,542,412 | 1,553,700 | 1,217,491 | 1,291,264 | 1,181,417 | 1,060,127 | Upgrade
|
| Operating Income | 996,798 | 952,669 | 920,276 | 1,052,281 | 1,076,078 | 860,784 | Upgrade
|
| Interest Expense | -19,436 | -25,635 | -24,811 | -29,530 | -12,559 | -12,080 | Upgrade
|
| Interest & Investment Income | 118,657 | 123,012 | 138,160 | 202,173 | 120,337 | 114,306 | Upgrade
|
| Currency Exchange Gain (Loss) | 1,639 | -578.16 | -2,514 | 5,580 | 3,587 | 4,160 | Upgrade
|
| Other Non Operating Income (Expenses) | -54,455 | -60,631 | -127,857 | -73,082 | -89,517 | -93,955 | Upgrade
|
| EBT Excluding Unusual Items | 1,043,203 | 988,837 | 903,254 | 1,157,423 | 1,097,926 | 873,214 | Upgrade
|
| Gain (Loss) on Sale of Investments | -87.5 | 192.5 | 262.5 | 315 | -772.55 | 274.7 | Upgrade
|
| Gain (Loss) on Sale of Assets | -2,423 | -2,430 | 967.73 | 1,437 | 2,518 | -7,999 | Upgrade
|
| Other Unusual Items | - | - | - | - | -58.33 | -1,488 | Upgrade
|
| Pretax Income | 1,040,692 | 986,599 | 904,485 | 1,159,174 | 1,099,613 | 864,002 | Upgrade
|
| Income Tax Expense | 138,900 | 134,245 | 125,564 | 108,512 | 111,159 | 87,717 | Upgrade
|
| Earnings From Continuing Operations | 901,792 | 852,354 | 778,920 | 1,050,663 | 988,455 | 776,285 | Upgrade
|
| Minority Interest in Earnings | - | - | - | - | - | 934.93 | Upgrade
|
| Net Income | 901,792 | 852,354 | 778,920 | 1,050,663 | 988,455 | 777,220 | Upgrade
|
| Preferred Dividends & Other Adjustments | 29,054 | 27,571 | 25,368 | 33,520 | 31,654 | 29,317 | Upgrade
|
| Net Income to Common | 872,738 | 824,783 | 753,553 | 1,017,143 | 956,801 | 747,903 | Upgrade
|
| Net Income Growth | 9.58% | 9.43% | -25.86% | 6.29% | 27.18% | 5.05% | Upgrade
|
| Shares Outstanding (Basic) | 131 | 131 | 131 | 131 | 131 | 131 | Upgrade
|
| Shares Outstanding (Diluted) | 131 | 131 | 131 | 131 | 131 | 131 | Upgrade
|
| Shares Change (YoY) | -0.84% | - | - | - | - | - | Upgrade
|
| EPS (Basic) | 6675.06 | 6308.29 | 5763.48 | 7779.53 | 7318.01 | 5720.27 | Upgrade
|
| EPS (Diluted) | 6675.06 | 6308.29 | 5763.48 | 7779.53 | 7318.01 | 5720.27 | Upgrade
|
| EPS Growth | 9.67% | 9.45% | -25.91% | 6.31% | 27.93% | 5.09% | Upgrade
|
| Free Cash Flow | 821,116 | 1,181,831 | 1,228,879 | -246,171 | 667,293 | 427,882 | Upgrade
|
| Free Cash Flow Per Share | 6280.23 | 9039.13 | 9398.97 | -1882.82 | 5103.73 | 3272.62 | Upgrade
|
| Dividend Per Share | - | - | 10000.000 | 7500.000 | 3500.000 | 3500.000 | Upgrade
|
| Dividend Growth | - | - | 33.33% | 114.29% | - | -12.50% | Upgrade
|
| Gross Margin | 48.18% | 47.59% | 43.76% | 46.73% | 48.28% | 47.98% | Upgrade
|
| Operating Margin | 18.91% | 18.09% | 18.84% | 20.98% | 23.01% | 21.50% | Upgrade
|
| Profit Margin | 16.56% | 15.66% | 15.43% | 20.28% | 20.46% | 18.68% | Upgrade
|
| Free Cash Flow Margin | 15.58% | 22.44% | 25.16% | -4.91% | 14.27% | 10.69% | Upgrade
|
| EBITDA | 1,115,027 | 1,070,698 | 1,089,971 | 1,140,985 | 1,157,079 | 943,348 | Upgrade
|
| EBITDA Margin | 21.16% | 20.33% | 22.31% | 22.75% | 24.75% | 23.57% | Upgrade
|
| D&A For EBITDA | 118,229 | 118,029 | 169,695 | 88,704 | 81,001 | 82,564 | Upgrade
|
| EBIT | 996,798 | 952,669 | 920,276 | 1,052,281 | 1,076,078 | 860,784 | Upgrade
|
| EBIT Margin | 18.91% | 18.09% | 18.84% | 20.98% | 23.01% | 21.50% | Upgrade
|
| Effective Tax Rate | 13.35% | 13.61% | 13.88% | 9.36% | 10.11% | 10.15% | Upgrade
|
| Revenue as Reported | 5,270,518 | 5,266,963 | 4,884,868 | 5,015,395 | 4,676,016 | 4,003,170 | Upgrade
|
| Advertising Expenses | - | 166,410 | 61,742 | 128,162 | 138,011 | 138,095 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.